BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37573200)

  • 1. [French recommendations for malignant pheochromocytomas and paragangliomas by the national ENDOCAN-COMETE network].
    de la Fouchardière C; Haissaguerre M; Decaussin-Petrucci M; Renaudin K; Deschamps F; Mirallié E; Murez T; Pattou F; Rocher L; Savoie PH; Faron M; Taieb D; Tabarin A; Bertherat J; Gimenez-Roqueplo AP; Amar L; Baudin E; Libé R
    Bull Cancer; 2023 Oct; 110(10):1063-1083. PubMed ID: 37573200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Guidelines of the French National ENDOCAN-COMETE, Association of Endocrine Surgery, Society of Urology for the management of adrenocortical carcinoma].
    Libé R; Haissaguerre M; Renaudin K; Faron M; Decaussin-Petrucci M; Deschamps F; Gimenez-Roqueplo AP; Mirallie E; Murez T; Pattou F; Rocher L; Taïeb D; Savoie PH; Tabarin A; Bertherat J; Baudin E; de la Fouchardière C
    Bull Cancer; 2023 Jun; 110(6):707-730. PubMed ID: 37061367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas.
    Mete O; Asa SL; Gill AJ; Kimura N; de Krijger RR; Tischler A
    Endocr Pathol; 2022 Mar; 33(1):90-114. PubMed ID: 35285002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [French ccAFU guidelines - Update 2018-2020: Adrenal cancer].
    Savoie PH; Murez T; Fléchon A; Sèbe P; Rocher L; Camparo P; Morel-Journel N; Ferretti L; Méjean A
    Prog Urol; 2018 Nov; 28 Suppl 1():R177-R195. PubMed ID: 31610872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric patients with pheochromocytoma and paraganglioma should have routine preoperative genetic testing for common susceptibility genes in addition to imaging to detect extra-adrenal and metastatic tumors.
    Babic B; Patel D; Aufforth R; Assadipour Y; Sadowski SM; Quezado M; Nilubol N; Prodanov T; Pacak K; Kebebew E
    Surgery; 2017 Jan; 161(1):220-227. PubMed ID: 27865588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetics and imaging of pheochromocytomas and paragangliomas: current update.
    Katabathina VS; Rajebi H; Chen M; Restrepo CS; Salman U; Vikram R; Menias CO; Prasad SR
    Abdom Radiol (NY); 2020 Apr; 45(4):928-944. PubMed ID: 31069476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. French AFU Cancer Committee Guidelines Update 2022-2024: Adrenal tumor -  Assessment of an adrenal incidetaloma and oncological management.
    Savoie PH; Murez T; Neuville P; Van Hove A; Rocher L; Fléchon A; Camparo P; Ferretti L; Branger N; Rouprêt M
    Prog Urol; 2022 Nov; 32(15):1040-1065. PubMed ID: 36400477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [COMETE, a network for the study and management of hypersecreting adrenal tumors].
    Plouin PF; Gimenez-Roqueplo AP; Bertagna X
    Bull Acad Natl Med; 2008 Jan; 192(1):73-82; discussion 83-5. PubMed ID: 18663983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative Management of Pheochromocytomas and Sympathetic Paragangliomas.
    Fagundes GFC; Almeida MQ
    J Endocr Soc; 2022 Feb; 6(2):bvac004. PubMed ID: 35128297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [French ccAFU guidelines - update 2020-2022: malignancy assessment of an adrenal incidentaloma].
    Savoie PH; Murez T; Fléchon A; Rocher L; Ferretti L; Morel-Journel N; Camparo P; Méjean A
    Prog Urol; 2020 Nov; 30(12S):S331-S352. PubMed ID: 33349429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas.
    Garcia-Carbonero R; Matute Teresa F; Mercader-Cidoncha E; Mitjavila-Casanovas M; Robledo M; Tena I; Alvarez-Escola C; Arístegui M; Bella-Cueto MR; Ferrer-Albiach C; Hanzu FA
    Clin Transl Oncol; 2021 Oct; 23(10):1995-2019. PubMed ID: 33959901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pheochromocytomas as adrenal gland incidentalomas].
    Cerović S; Cizmić M; Milović N; Ajdinović B; Brajusković G
    Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():47-51. PubMed ID: 12584998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pheochromocytomas and Paragangliomas: An Update on Recent Molecular Genetic Advances and Criteria for Malignancy.
    Guo Z; Lloyd RV
    Adv Anat Pathol; 2015 Sep; 22(5):283-93. PubMed ID: 26262510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant pheochromocytomas and paragangliomas: a diagnostic challenge.
    Gimm O; DeMicco C; Perren A; Giammarile F; Walz MK; Brunaud L
    Langenbecks Arch Surg; 2012 Feb; 397(2):155-77. PubMed ID: 22124609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pheochromocytomas in adrenal medulla or extra-adrenal and multiple endocrine neoplasms:a clinicopathologic analysis of 181 cases].
    Jiang CX; Zeng Z; Wang T; Liu X; Liu R; Li Y
    Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):762-6. PubMed ID: 22336161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stathmin expression in pheochromocytomas, paragangliomas, and in other endocrine tumors.
    Sadow PM; Rumilla KM; Erickson LA; Lloyd RV
    Endocr Pathol; 2008; 19(2):97-103. PubMed ID: 18461287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pheochromocytoma and extra-adrenal paraganglioma: updates.
    Tischler AS
    Arch Pathol Lab Med; 2008 Aug; 132(8):1272-84. PubMed ID: 18684026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical and postsurgical management of abdominal paragangliomas and pheochromocytomas.
    Araujo-Castro M; Pascual-Corrales E; Lorca Álvaro J; Mínguez Ojeda C; Pian H; Ruz-Caracuel I; Sanjuanbenito Dehesa A; Serrano Romero AB; Alonso-Gordoa T; Molina-Cerrillo J; Gómez Dos Santos V
    Actas Urol Esp (Engl Ed); 2023 Mar; 47(2):68-77. PubMed ID: 37078847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators.
    Ayala-Ramirez M; Feng L; Johnson MM; Ejaz S; Habra MA; Rich T; Busaidy N; Cote GJ; Perrier N; Phan A; Patel S; Waguespack S; Jimenez C
    J Clin Endocrinol Metab; 2011 Mar; 96(3):717-25. PubMed ID: 21190975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment for Malignant Pheochromocytomas and Paragangliomas: 5 Years of Progress.
    Jimenez P; Tatsui C; Jessop A; Thosani S; Jimenez C
    Curr Oncol Rep; 2017 Oct; 19(12):83. PubMed ID: 29081018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.